ATP最大3.48/8TBのストレージを備えたNVMe M.2/U.2 SSD用の銅箔、フィンタイプ・ヒートシンク/サーマルパッドを発表
March 28, 2021 21:00 ET
|
ATP Electronics Taiwan Inc.
台湾・台北, March 29, 2021 (GLOBE NEWSWIRE) -- 台湾・台北（2021年3月) – 特殊ストレージとメモリ・ソリューションの世界的リーダーであるATP Electronicsは、カスタマイズ可能な熱管理機能を備えた新しいNVMe Flashストレージ・ソリューションの発売を発表しました。...
ATP華騰國際發表高容量儲存記憶體 3.84及8 TB銅箔與鰭狀散熱片式NVMe M.2/U.2 固態硬碟
March 28, 2021 21:00 ET
|
ATP Electronics Taiwan Inc.
台灣台北, March 29, 2021 (GLOBE NEWSWIRE) -- 專注於儲存與記體體解決方案的領導廠商華騰國際科技(ATP Electronics)新發表客製化熱管理NVMe快閃記憶體解決方案。運用硬體與韌體配置，強化記憶體熱管理解決方案，特別針對NVMe介面的固態硬碟(Solid State Drives,...
ATP bietet NVMe M.2 / U.2 SSDs für Hochtemperaturapplikationen
March 28, 2021 21:00 ET
|
ATP Electronics Taiwan Inc.
TAIPEH, Taiwan, March 29, 2021 (GLOBE NEWSWIRE) -- ATP Electronics, ein führender Anbieter von spezialisierten Speicherlösungen, stellt neue NVMe-Flash-Speicherlösungen mit adaptivem Wärmemanagement...
ATP Introduces Copper Foil, Fin-Type Heatsink / Thermal Pad for NVMe M.2/U.2 SSDs with up to 3.84/8 TB Storage
March 28, 2021 21:00 ET
|
ATP Electronics Taiwan Inc.
TAIPEI, Taiwan, March 28, 2021 (GLOBE NEWSWIRE) -- ATP Electronics, the global leader in specialized storage and memory solutions, announced the launch of its new NVMe flash storage solutions with...
TLC Reports Fiscal Year End 2020 Financial Results and Provides Business Update
February 05, 2021 04:15 ET
|
TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Feb. 05, 2021 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines...
TLC Reports Third Quarter 2020 Financial Results and Provides Business Update
October 28, 2020 04:51 ET
|
TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Oct. 28, 2020 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...
TLC Announces the Appointment of Thomas H. Bliss, Jr., MBA, as Chief Business Officer
October 21, 2020 04:45 ET
|
TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Oct. 21, 2020 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage, specialty pharmaceutical company developing novel nanomedicines to...
TLC to Present at Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit
September 21, 2020 04:45 ET
|
TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Sept. 21, 2020 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...
TLC to Present at Cantor Virtual Global Healthcare Conference
September 11, 2020 04:45 ET
|
TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Sept. 11, 2020 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...
TLC Reports Second Quarter 2020 Financial Results and Provides Business Update
August 05, 2020 05:00 ET
|
TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Aug. 05, 2020 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...